Challenges with Pharmaceutical Waste Management in the Healthcare Industry

STEVE TODISCO | March 13, 2017

article image
For more than a decade, the healthcare industry has grappled with confusing regulations around pharmaceutical waste management. These regulations can vary widely from state to state and have a big impact on organizational compliance. As regulations are constantly changing and nursing staff and other similar departments have other focuses, keeping everyone in-the-know is challenging.

Spotlight

Mylan Laboratories Limited

Mylan India is a part of Mylan Inc. U.S one of the world’s leading generic and specialty pharmaceutical companies. In India we have strong manufacturing base with Active Pharmaceutical Ingredients, Oral Solid Dosage and Injectable units spread across the country. The company also has exceptional R&D facilities and fast growing commercial operations in India. Mylan India comprises of nearly 50% of Mylan Inc.’s total global workforce.

OTHER ARTICLES

What do you have to lose taking hydroxychloroquine for coronavirus? Potentially your life

Article | April 10, 2020

The president and some of his close advisors — desperate for a COVID-19 cure — are asking “What do you have to lose?” by taking hydroxychloroquine (HCQ), a strong medication never adequately tested for efficacy or safety in COVID-19 patients. The correct answer to the president’s question, which he doesn’t seem to want to hear, is that we have our lives to lose. The president acknowledges “I’m not a doctor” but this raises the question “What do doctors know about the drug recommended by the president? Most doctors are aware that HCQ can be effective for patients with malaria, arthritis or lupus. If they were to follow the president’s suggestion and prescribe it for COVID-19 patients, they would also like to know that it will benefit some of those patients, at least.

Read More

5 Pharma Trends and Their Impact on Packaging

Article | April 10, 2020

The pharmaceutical industry is changing at an unprecedented pace. New biological treatments for cancer, and a dramatic rise of widespread diseases such as diabetes, call for new processing and packaging solutions to fulfill the different needs all over the world. Keep your eye on these five main packaging trends for 2020 for the global pharmaceutical market.

Read More

Global Antiviral Drugs Market Growth: Is Antiviral Drug the Best Coronavirus Treatment?

Article | April 10, 2020

The global antiviral drugs market has witnessed a rapid surge in demand due to the ongoing Covid-19 pandemic worldwide. So is antiviral drug the best coronavirus treatment? It is still too early to have that conclusion as many medical research and clinical trials are still trying to find the effectiveness and potential side effects of using antiviral drugs to treat coronavirus. But experts believe that antiviral drug might be the best hope for reduce the coronavirus transmission around the world at this stage. However, due to the current difficult situation of the supply chain in many lockdown countries and regions, there is a global shortage on the antiviral drugs supply. With researchers and manufacturers working hard to find and provide effective coronavirus treatment, it is expected that the global antiviral drugs market will have a significant growth over the near future. Antiviral drugs are a type of medication used specifically for treating viral infections, such as human immunodeficiency virus (HIV), hepatitis, and influenza.

Read More

Advance Your Pharma Supply Chain Planning during a Pandemic

Article | April 10, 2020

One predominant and common element within our pharmaceutical industry, is our devotions to patients. Within supply chain there is always a focus on ensuring the right product is delivered to the right place at the right time in order to ensure patient safety and the continuity of medicinal supplies. With the spread of COVID-19 across 117 countries and counting, every supply chain needs to evaluate their global footprint and develop contingency plans within their end to end operations.

Read More

Spotlight

Mylan Laboratories Limited

Mylan India is a part of Mylan Inc. U.S one of the world’s leading generic and specialty pharmaceutical companies. In India we have strong manufacturing base with Active Pharmaceutical Ingredients, Oral Solid Dosage and Injectable units spread across the country. The company also has exceptional R&D facilities and fast growing commercial operations in India. Mylan India comprises of nearly 50% of Mylan Inc.’s total global workforce.

Events